Join

Compare · AVTR vs HBIO

AVTR vs HBIO

Side-by-side comparison of Avantor Inc. (AVTR) and Harvard Bioscience Inc. (HBIO): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AVTR and HBIO operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • AVTR is the larger of the two at $6.77B, about 248.4x HBIO ($27.2M).
  • Over the past year, AVTR is down 27.6% and HBIO is up 5.5% - HBIO leads by 33.1 points.
  • AVTR has been more active in the news (3 items in the past 4 weeks vs 2 for HBIO).
  • AVTR has more recent analyst coverage (25 ratings vs 2 for HBIO).
PerformanceAVTR-27.59%HBIO+5.46%
2025-06-10+0.00%2026-06-09
MetricAVTRHBIO
Company
Avantor Inc.
Harvard Bioscience Inc.
Price
$9.92+2.43%
$6.20-3.58%
Market cap
$6.77B
$27.2M
1M return
+19.52%
-11.43%
1Y return
-27.59%
+5.46%
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NYSE
NASDAQ
IPO
2019
2000
News (4w)
3
2
Recent ratings
25
2
AVTR

Avantor Inc.

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

HBIO

Harvard Bioscience Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. It offers physiology, cell, and molecular instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. The company also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products, systems, services, and solutions with a focus on physiologic monitoring solutions. It markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. The company primarily sells its products under Harvard Apparatus, Biochrom, Hoefer, Panlab, Warner Instruments, Hugo Sachs Elektronik, Scie-Plas, BTX, Multi Channel Systems, HEKA, DSI, Ponemah, and Buxco brand names in North America, Europe, China, and internationally. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.

Latest AVTR

Latest HBIO